"The impact of aromatase inhibitors is particularly remarkable given how specific these drugs are," lead author of the aromatase-inhibitor study, Professor Mitch Dowsett of The Royal Marsden and ...

Mar. 24 -- TUESDAY, March 11 (HealthDay News) -- There's good news for the 60 percent of women with breast cancer whose malignancies are estrogen-driven: Researchers say taking the aromatase ...

How many, if any, cases of nervous system disorders have been reported because of A-C breast cancer chemotherapy? I'm 45 and had treatment at 39 and 40. I now experience a very exaggerated amount of ...

On the other, the Institute was to assess whether the 3 approved drugs from the drug class of aromatase inhibitors (anastrozole, exemestane, letrozole) differ with regard to benefit or harm.

Aromatase inhibitor letrozole guards against breast cancer relapse for up to 8 years, study finds Date: September 25, 2011 ... using drugs that target hormones such as oestrogen, ...

However, patients commonly develop resistance to aromatase inhibitor drugs, and they stop working. This is also known as endocrine therapy resistance. Metastatic breast cancer treatments in ...

2002-05-20 04:00:00 PDT Orlando, Fla.-- The nation's leading group of cancer specialists said Sunday that it was premature for post-menopausal women with early breast cancer to switch to a newer ...

A new study shows that a type of androgen-blocking drug, an aromatase inhibitor (marketed since 2005 to reduce the risk of breast cancer) is at least as effective against a common hormonal disorder as ...

Aromatase inhibitors, drugs which block oestrogen production, are even more effective than tamoxifen in postmenopausal women, reducing this risk by a further 30%.

Aromatase inhibitors (AIs), like arimidex, aromasin and femara, are also used to help fight cancer cell regrowth. These drugs work to block cell receptors like estrogen and progesterone in breast ...

Aromatase inhibitors work to lower your levels of estrogen. These oral meds are usually taken once a day. They include the drugs letrozole (Femara), anastrozole (Arimidex), and exemestane (Aromasin).